OpportunityTitle: HIV Vaccine Research and Design (HIVRAD) Program (P01)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:   Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Description: Purpose. The NIAID held a Vaccine Summit in March 2008 to solicit input on how best to advance the field of HIV vaccine discovery research. The HIV Vaccine Research and Design (HIVRAD) Program, a multi-project, multidisciplinary HIV/AIDS prophylactic vaccine-related funding mechanism is one such mechanism that may be used for support of the research priorities identified at the NIAID Vaccine Summit. Mechanism of Support. The NIH Program Project (P01) mechanism will be used for this Program Announcement. Applications must include at least two (2) projects and one (1) core. Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received. However, it is anticipated that 1-2 new awards will be made per year.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster &lt;br/&gt;FBOWebmaster@OD.NIH.GOV